D0540

DNQX

≥98% (TLC), kainate, quisqualate (non-NMDA) glutamate receptor antagonist, powder

• Synonim(y): 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione
• Wzór empiryczny (zapis Hilla): C₈H₄N₄O₆
• Numer CAS: 2379-57-9
• Masa cząsteczkowa: 252.14
• UNSPSC Code: 51111800
• PubChem Substance ID: 24277973
• NACRES: NA.77
• MDL number: MFCD00069257
• Assay: ≥98% (TLC)
• Form: powder

Właściwości

• Nazwa produktu: DNQX, ≥98% (TLC)
• Quality Segment: 200
• assay: ≥98% (TLC)
• form: powder
• SMILES string: [O-][N+](=O)c1cc2NC(=O)C(=O)Nc2cc1[N+]([O-])=O
• InChI: 1S/C8H4N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H,(H,9,13)(H,10,14)
• InChI key: RWVIMCIPOAXUDG-UHFFFAOYSA-N
• Gene Information: human ... GRIA1(2890), GRIA2(2891), GRIK1(2897), GRIK2(2898), GRIK3(2899), GRIK4(2900), GRIK5(2901) ; mouse ... Gria1(14799) ; rat ... Gria1(50592), Grik1(29559), Grik4(24406), Grin2a(24409)

Opis

Application

DNQX has been used to block N-Methyl-D-aspartic acid (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in various experiments.

Biochem/physiol Actions

A competitive kainate, quisqualate (non-NMDA) glutamate receptor antagonist.

DNQX is a quinoxaline derivative.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.